WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 05-Dec-2014 (Data received as of 1-Dec-2014)
Next overall update June 2015
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 102
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 112

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 3'369  3'250  3'125  2'992  2'850  1'906  2'060  1'371 
Births 69  67  65  63  61  44  37  54 
Surviving infants 68  67  65  63  60  44  37  53 
Pop. less than 5 years 324  314  301  285  273  187  235  212 
Pop. less than 15 years 835  811  784  754  722  489  721  548 
Female 15-49 years 820  789  757  724  689  475  547  280 

Number of reported case

(Click for retrospective incidence data for Kuwait)
Diphtheria
Japanese encephalitis
Measles 62  27  32  13  71  1'382 
Mumps 45  61  62  91  76 
Pertussis 30  83  16  41  43  25  69 
Polio* 32 
Rubella 13  38  26  87 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total) 15 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Kuwait)
Vaccine year result method % card seen                                                
BCG 1995  26  FHS   75  99  97  99  98  99 
DTP1 1995  94  FHS   75  97  97  98  98  99  97 
DTP3          99  98  99  98  99  98  67 
HepB_BD          98  97  98  99  94 
HepB3          99  98  99  99  99  95 
Hib3          99  98  99  98  99  98 
JapEnc         
MCV          100  99  99  98  99  99  48 
MCV2          99  99  99  99  94 
PCV1          97  97  98  98 
PCV3          99  99  100  98  99 
Pol3          99  98  99  98  99  94  70 
Rota1         
Rota_last         
Rubella1          100  99  99  98 
TT2plus          74  47 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Kuwait)
BCG 99  97  99  98  99 
DTP1 99  99  99  98  99  98  88  86 
DTP3 99  98  99  98  99  98  71  67 
HepB3 99  98  99  99  99  95 
HepB_BD 98  97  98  99  99  94 
Hib3 99  98  99  98  99  98 
MCV 99  99  99  98  99  99  66  48 
MCV2 99  99  99  99  94 
PAB 95  95  95  95  84  77  51 
PnC3 99  99  99  98  99 
Pol3 99  98  99  98  99  94  71  70 
Rota_last

Number of districts in the country 109  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 0
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 3 months; Yes
DT No where pertussis is contraindicated
DTwP 3.6 years; Yes
DTwPHibHepB 2, 4, 6, 18 months; Yes
HepB birth; Yes and adults &HCW
IPV 2 months; Yes
Influenza No adults in high risk groups
MMR 1, 2, 12 years; Yes at 12 years for girls
MenAC No special expatriate working groups
MenACWY 2 years; Yes
OPV 4, 6, 12, 18 months; Yes
Pneumo_conj 2, 4, 6, 18 months; Yes
Pneumo_ps No adults at risk and pilgrims
TT Yes pregnants - high risk groups
Td 10, 18 years; Yes
Typhoid No food handlers
Varicella No HCW at risk
YF travellers to endemic areas

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes       
What years does the MYP cover? number 2 YEARS  2013-2014  2 years         
Nº of districts with microplans that include activities to raise immunization coverage number 109  109  109  109       

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes       

System performance

Total Nº districts in country number 109  109  109  109       
Nº districts with DTP3 coverage >=80% number        
% of districts with DTP3 coverage >=80% From 0 to 100%        
Nº districts with measles (MCV1) coverage >=95% number              
% of districts with MCV1 coverage >=95% From 0 to 100%              

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR No  No  No  No       

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100%            

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.